It is expressed physiologically in pancreas, intestine, lung, kidney, breast and brain, and overexpressed in such pathologies as insulinomas, gastrinomas, and phaeochromocytomas with the highest GLP-1R incidence and density in insulinomas 32, 33, 42. This evidence concerns the gene GLP1R and pheochromocytoma.